EVP, General Counsel, Corp Sec
Thu, Mar 4, 2021
Mar 4
exercised or converted securities in ANIK
2,500 shares @ $0.00
New position
ANIKAnika Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W-1.07%
1M+42.74%
3M+44.09%
6M—
1Y—